TY - JOUR
T1 - Vaccination of Immunocompromised Cats
AU - Hartmann, Katrin
AU - Möstl, Karin
AU - Lloret Roca, Albert
AU - Thiry, Etienne
AU - Addie, Diane D.
AU - Belák, Sándor
AU - Boucraut-Baralon, Corine
AU - Egberink, Herman
AU - Frymus, Tadeusz
AU - Hofmann-Lehmann, Regina
AU - Lutz, Hans
AU - Marsilio, Fulvio
AU - Pennisi, Maria Grazia
AU - Tasker, Séverine
AU - Truyen, Uwe
AU - Hosie, Margaret J.
PY - 2022
Y1 - 2022
N2 - Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.
AB - Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.
KW - Feline
KW - Immunocompromise
KW - Immunosuppression
KW - Immunodeficiency
KW - Vaccine
KW - Efficacy
KW - Safety
KW - Duration of immunity
KW - DOI
UR - https://www.scopus.com/pages/publications/85129834912
U2 - 10.3390/v14050923
DO - 10.3390/v14050923
M3 - Article
C2 - 35632665
SN - 1999-4915
VL - 14
JO - Viruses
JF - Viruses
ER -
